Articles can be viewed by the current month and the archive. If nothing appears on the page, then please select the archive option on the left.
Ethnicity modifies link between HbA1c and FPG in Asian populations
The use of glycated hemoglobin in place of fasting plasma glucose as an indicator for glycemic status will reclassify Asian individuals’ diabetes status differently depending on their ethnicity, show study findings.
3 February 2012
The use of glycated hemoglobin in place of fasting plasma glucose as an indicator for glycemic status will reclassify Asian individuals’ diabetes status differently depending on their ethnicity, show study findings.
Liraglutide benefits overall CV risk profile in diabetes
In patients with diabetes that is well controlled with metformin monotherapy, the addition of liraglutide improves several cardiovascular risk factors beyond glycemic control, suggest study findings.
2 February 2012
In patients with diabetes that is well controlled with metformin monotherapy, the addition of liraglutide improves several cardiovascular risk factors beyond glycemic control, suggest study findings.
Pitavastatin beats pravastatin at improving albuminuria in diabetes
Pitavastatin is more effective than pravastatin at reducing albuminuria in Type 2 diabetes patients with early-stage diabetic nephropathy, show study findings.
2 February 2012
Pitavastatin is more effective than pravastatin at reducing albuminuria in Type 2 diabetes patients with early-stage diabetic nephropathy, show study findings.
Leptin levels rise after cardiopulmonary bypass in diabetes patients
The acute stress response in leptin appears to be higher in patients with diabetes compared with those without, show study findings.
1 February 2012
The acute stress response in leptin appears to be higher in patients with diabetes compared with those without, show study findings.
HbA1c target more achievable with earlier insulin initiation in Type 2 diabetes
Starting patients on insulin therapy at lower levels of glycated hemoglobin improves achievement of glycemic control and increases glycemic response in Type 2 diabetes patients, report US researchers.
31 January 2012
Starting patients on insulin therapy at lower levels of glycated hemoglobin improves achievement of glycemic control and increases glycemic response in Type 2 diabetes patients, report US researchers.
Exenatide or sitagliptin not linked to acute renal failure in diabetes
Use of exenatide or sitagliptin in treating diabetes does not appear to be associated with an increased risk for acute renal failure relative to use of metformin, sulfonylureas, or thiazolidinediones, show study findings.
31 January 2012
Use of exenatide or sitagliptin in treating diabetes does not appear to be associated with an increased risk for acute renal failure relative to use of metformin, sulfonylureas, or thiazolidinediones, show study findings.
